- Axsome Therapeutics : Ladenburg Thalmann adjusts pt to $162 from $186, maintains buy rating
- Berkshire Hills: Piper Sandler downgrades to neutral from overweight. PT up 8.4% to $31
- BioNTech: Bryan Garnier & Co raised the recommendation on BioNTech SE ADRs to buy from neutral. PT up 8.3% to $451
- Callaway Golf : Stephens adjusts price target to $40 from $37, maintains overweight rating
- Cerence : Goldman Sachs adjusts pt to $134 from $124, maintains buy rating
- Flutter: JP Morganmaintains his Buy rating on the stock. The target price is increased from GBp 16290 to GBp 17250.
- Fusion Pharmaceuticals : Wedbush reduces price target to $21 from $24, outperform rating kept
- Hargreaves Lansdown: Jefferies remains Hold with a reduced target price of GBp 1,640 to 1,350.
- International Consolidated Airlines Group: Liberum raised the recommendation to buy from hold. PT up 29% to 215 pence
- L3Harris: Morgan Stanley downgrades to equal-weight from overweight. PT up 2.3% to $238
- Qualys : JPMorgan adjusts price target to $110 from $90, maintains underweight rating
- SSE: Jefferies remains a Hold with a price target raised from GBp 1680 to GBp 1710.
- STERIS : Needham lifts price target to $254 from $233, buy rating kept
- Synaptics: Arete downgrades to neutral from buy. PT up 2.2% to $175
- Travis Perkins: Jefferies remains Buy with a target price raised from GBP 2150 to 2168.
- Tyson Foods : BMO Capital adjusts price target to $95 from $84, maintains outperform rating
- Virgin Galactic: Morgan Stanley downgrades to underweight from equal-weight. PT down 20% to $25
- WW International: Jefferies downgrades to hold from buy. PT down 7.1% to $30